Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells

Biochemical Pharmacology

Volumn 79, Issue 10, 2010, Pages 1516-1525

  Shu, Xiao Hong ^a   Li, Hong ^a   Sun, Zheng ^a   Wu, Mo Li ^a   Ma, Jing Xin ^a   Wang, Jian Min ^a   Wang, Qian ^a   Sun, Yuan ^a   Fu, Yuan Shan ^a   Chen, Xiao Yan ^a   Kong, Qing You ^a   Liu, Jia ^a  

^a Liaoning Laboratory of Cancer Genomics   (China)

Author keywords

Chemosensitivity; Drug metabolism; Medulloblastoma; Resveratrol; Sulfotransferase

Indexed keywords

DRUG METABOLITE; RESVERATROL; RESVERATROL MONOSULFATE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1C2; SULFOTRANSFERASE 4A1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CANCER CELL CULTURE; CANCER TISSUE; CELL LYSATE; CHILD; CIS TRANS ISOMERISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG METABOLISM; DRUG SENSITIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDULLOBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHOOL CHILD;

ADOLESCENT; ANIMALS; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; BLOTTING, WESTERN; CELL LINE, TUMOR; CEREBELLAR NEOPLASMS; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MEDULLOBLASTOMA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES; SULFOTRANSFERASES; YOUNG ADULT;

EID: 77649189281     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.01.022     Document Type: Article

References (47)

1. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
2. Dixon R.A. Natural products and plant disease resistance. Nature 411 (2001) 843-847
3. Rivera L., Morón R., Zarzuelo A., and Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77 (2009) 1053-1063
4. Burstein B., Maguy A., Clément R., Gosselin H., Poulin F., Ethier N., et al. Effects of resveratrol (trans-3,5,4′-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction. J Pharmacol Exp Ther 323 (2007) 916-923
5. Olas B., and Wachowicz B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 106 (2002) 143-148
6. Zhu J., Yong W., Wu X., Yu Y., Lv J., Liu C., et al. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun 369 (2008) 471-477
7. Shakibaei M., Csaki C., Nebrich S., and Mobasheri A. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76 (2008) 1426-1439
8. Hudson T.S., Hartle D.K., Hursting S.D., Nunez N.P., Wang T.T., Young H.A., et al. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 67 (2007) 8396-8405
9. Aziz M.H., Reagan-Shaw S., Wu J., Longley B.J., and Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?. FASEB J 19 (2005) 1193-1195
10. Boissy P., Andersen T.L., Abdallah B.M., Kassem M., Plesner T., and Delaissé J.M. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 65 (2005) 9943-9952
11. Zhang P., Li H., Wu M.L., Chen X.Y., Kong Q.Y., Wang X.W., et al. c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells. J Neurooncol 80 (2006) 123-131
12. Danz E.D., Skramsted J., Henry N., Bennett J.A., and Keller R.S. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med 46 (2009) 1589-1597
13. Venkatesan B., Ghosh-Choudhury N., Das F., Mahimainathan L., Kamat A., Kasinath B.S., et al. Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B. FASEB J 22 (2008) 3469-3482
14. Wang Q., Xu J., Rottinghaus G.E., Simonyi A., Lubahn D., Sun G.Y., et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958 (2002) 439-447
15. Wang Q., Li H., Liu N., Chen X.Y., Wu M.L., Zhang K.L., et al. Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells. Neurosci Lett 438 (2008) 168-173
16. Yu L.J., Wu M.L., Li H., Chen X.Y., Wang Q., Sun Y., et al. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 10 (2008) 736-744
17. Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2 (2009) 409-418
18. Li Y., Bäckesjö C.M., Haldosén L.A., and Lindgren U. Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells. Eur J Pharmacol 609 (2009) 13-18
19. Woo K.J., Lee T.J., Lee S.H., Lee J.M., Seo J.H., Jeong Y.J., et al. Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells. Biochem Pharmacol 73 (2007) 68-76
20. Gescher A.J., and Steward W.P. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12 (2003) 953-957
21. Ellison D.W., Onilude O.E., Lindsey J.C., Lusher M.E., Weston C.L., Taylor R.E., et al. Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23 (2005) 7951-7957
22. Marino S. Medulloblastoma: developmental mechanisms out of control. Trends Mol Med 11 (2005) 17-22
23. Liu J., Guo L., Luo Y., Li J.W., and Li H. All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells. Anticancer Res 20 (2000) 2659-2664
24. Wang Q., Li H., Wang X.W., Wu D.C., Chen X.Y., and Liu J. Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett 351 (2003) 83-86
25. Keles G.E., Berger M.S., Srinivasan J., Kolstoe D.D., Bobola M.S., and Silber J.R. Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res 7 (1995) 493-503
26. Chen X., He H., Wang G., Yang B., Ren W., Ma L., et al. Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies. Biomed Chromatogr 21 (2007) 257-265
27. Mercolini L., Addolorata Saracino M., Bugamelli F., Ferranti A., Malaguti M., Hrelia S., et al. HPLC-F analysis of melatonin and resveratrol isomers in wine using an SPE procedure. J Sep Sci 31 (2008) 1007-1014
28. Qian G., Leung S.Y., Lu G., and Leung K.S. Optimization and validation of a chromatographic method for the simultaneous quantification of six bioactive compounds in Rhizoma et Radix Polygoni Cuspidati. J Pharm Pharmacol 60 (2008) 107-113
29. Boocock D.J., Patel K.R., Faust G.E., Normolle D.P., Marczylo T.H., Crowell J.A., et al. Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B 848 (2007) 182-187
30. Urpi-Sarda M., Zamora-Ros R., Lamuela-Raventos R., Cherubini A., Jauregui O., de la Torre R., et al. HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin Chem 53 (2007) 292-299
31. Salman E.D., Kadlubar S.A., and Falany C.N. Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. Drug Metab Dispos 37 (2009) 706-709
32. Liyou N.E., Buller K.M., Tresillian M.J., Elvin C.M., Scott H.L., Dodd P.R., et al. Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study. J Histochem Cytochem 51 (2003) 1655-1664
33. Allali-Hassani A., Pan P.W., Dombrovski L., Najmanovich R., Tempel W., Dong A., et al. Structural and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol 5 (2007) 1063-1078
34. Hui Y., Yasuda S., Liu M.Y., Wu Y.Y., and Liu M.C. On the sulfation and methylation of catecholestrogens in human mammary epithelial cells and breast cancer cells. Biol Pharm Bull 31 (2008) 769-773
35. Wang D.G., Hang T.J., Wu C.Y., and Liu W.Y. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J Chromatogr B 829 (2005) 97-106
36. Murias M., Miksits M., Aust S., Spatzenegger M., Thalhammer T., Szekeres T., et al. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261 (2008) 172-181
37. Walle T., Hsieh F., DeLegge M.H., Oatis J.E., and Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32 (2004) 1377-1382
38. Alnouti Y., and Klaassen C.D. Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93 (2006) 242-255
39. Lindsay J., Wang L.L., Li Y., and Zhou S.F. Structure, function and polymorphism of human cytosolic sulfotransferases. Curr Drug Metab 39 (2008) 99-105
40. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5 (2006) 493-506
41. Lançon A., Hanet N., Jannin B., Delmas D., Heydel J.M., Lizard G., et al. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos 35 (2007) 699-703
42. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae life span. Nature 425 (2003) 191-196
43. Lee S.K., Zhang W., and Sanderson B.J. Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction. J Agric Food Chem 56 (2008) 7572-7577
44. Holcapek M., Kolárová L., and Nobilis M. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Anal Bioanal Chem 391 (2008) 59-78
45. Yang J., Zhao X.J., Liu X.L., Wang C., Gao P., Wang J.S., et al. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res 5 (2006) 554-561
46. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J 17 (2003) 1975-1985
47. Liska D., Lyon M., and Jones D.S. Detoxification and biotransformational imbalances. Explore (NY) 2 (2006) 122-140